Want to see SE:BOUL full AI Analyst Report?
Boule Diagnostics AB (BOUL) Financial Statements
Boule Diagnostics AB Financial Overview
Boule Diagnostics AB's market cap is currently $40.19M. The company's EPS TTM is $-0.45; its P/E ratio is -2.31; and it has a dividend yield of 1.06%. Boule Diagnostics AB is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 489.70M | $ 558.60M | $ 571.33M | $ 548.09M | $ 463.34M |
| Gross Profit | $ 213.80M | $ 252.40M | $ 249.71M | $ 227.91M | $ 198.63M |
| Operating Income | $ 4.52M | $ -257.40M | $ 39.30M | $ 28.97M | $ 36.02M |
| EBITDA | $ 23.12M | $ -255.90M | $ 65.98M | $ 57.84M | $ 55.69M |
| Net Income | $ -3.80M | $ -223.30M | $ 24.98M | $ 12.73M | $ 23.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 19.60M | $ 22.70M | $ 37.28M | $ 96.90M | $ 38.18M |
| Total Assets | $ 469.60M | $ 590.20M | $ 755.11M | $ 759.96M | $ 572.03M |
| Total Debt | $ 223.76M | $ 195.00M | $ 166.17M | $ 189.97M | $ 155.44M |
| Net Debt | $ 204.16M | $ 172.30M | $ 128.89M | $ 93.06M | $ 117.26M |
| Total Liabilities | $ 301.90M | $ 320.60M | $ 280.01M | $ 297.46M | $ 276.30M |
| Stockholders' Equity | $ 167.60M | $ 269.60M | $ 475.10M | $ 462.50M | $ 295.74M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.13M | $ -39.30M | $ -31.30M | $ -86.31M | $ -13.09M |
| Operating Cash Flow | $ 829.00K | $ 46.60M | $ 51.38M | $ -11.35M | $ 43.28M |
| Investing Cash Flow | $ -5.00M | $ -85.90M | $ -82.71M | $ -74.96M | $ -56.37M |
| Financing Cash Flow | $ 3.30M | $ 24.40M | $ -25.51M | $ 140.55M | $ 15.75M |
Currency in SEK